Hepalink declares final dividend for 2024, updates key details

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has declared a final dividend of RMB 2.5 per 10 shares for the financial year ending December 31, 2024, as approved by shareholders on May 22, 2025. The dividend, classified as ordinary, will be paid in HKD at HKD 2.7165 per 10 shares based on an exchange rate of RMB 1: HKD 1.0866. The ex-dividend date is set for May 26, 2025, with a record date of May 30, 2025, and a payment date of July 22, 2025.